Immunosuppressive Therapy in Whipple's Disease Patients is Associated with the Appearance of Gastrointestinal Manifestations

Mahnel, Ren; Kalt, Anja; Ring, Sabine; Stallmach, Andreas; Strober, Warren; Marth, Thomas
May 2005
American Journal of Gastroenterology;May2005, Vol. 100 Issue 5, p1167
Academic Journal
OBJECTIVES: Whipple's disease is a rare chronic disorder, which is caused by systemic infection withTropheryma whipplei. The first symptom of Whipple's disease usually is a nondestructive polyarthritis resembling in many aspects seronegative rheumatoid arthritis. This polyarticular inflammatory arthropathy preceding the diagnosis of Whipple's disease for several years frequently is treated with nonsteroidal antiinflammatory drugs (NSAIDs) and with immunosuppressive therapy. There is evidence that altered immune functions play a role in the manifestation of the disease and that Whipple's disease is associated with opportunistic infections. We therefore asked whether immunosuppressive treatment for arthropathy may alter the course of Whipple's disease.PATIENTS AND METHODS: In a series of 27 patients with Whipple's disease clinical data were documented and the patients were followed for 3–4 yr. The patients were classified into three groups according to their medication: (i) patients with immunosuppressive therapy preceding the diagnosis, (ii) patients with NSAIDs before diagnosis, and (iii) patients without such therapies.RESULTS: Arthropathies occurred in the mean 8 yr before diagnosis and were the first symptom in 63% of the patients. Gastrointestinal involvement usually became evident later on and frequently led to the diagnosis of Whipple's disease. In patients with immunosuppressive treatment, diarrhea occurred in the median 4 months after the initiation of such therapy and diagnosis of Whipple's disease was made after another 2 months. In contrast, other medical treatments were not closely followed by the onset of diarrhea.CONCLUSIONS: These results indicate an association between immunosuppressive therapy and the onset of diarrhea in Whipple's disease and thus support the concept that immunologic factors play a role in disease pathogenesis. Further investigation on the interaction of the immune system andTropheryma whippleiinfection are required to understand the factors contributing to the clinical manifestation of this rare disorder and possibly to introduce preventive interventions.(Am J Gastroenterol 2005;100:1167–1173)


Related Articles

  • The long-term outcomes from a randomized controlled trial of an educational–behavioural joint protection programme for people with rheumatoid arthritis. Hammond, A.; Freeman, K. // Clinical Rehabilitation;Aug2004, Vol. 18 Issue 5, p520 

    Objective: To evaluate the long-term effects of joint protection on health status of people with early rheumatoid arthritis (RA). Design: A four-year follow-up of a randomized, controlled, assessor-blinded trial was conducted. Setting: Two rheumatology outpatient departments. Participants:...

  • Psöriyatik Artrit Tedavisi. Bodur, Hatice // Turkish Journal of Physical Medicine & Rehabilitation / Turkiye ;abr2008, Vol. 54 Issue 2, p31 

    Psoriatic arthritis (PsA) is chronic inflammatory arthropathy of peripheral joints, spine and enthesis. In the past, it was considered that PsA progresses mildly compared to Rheumatoid Arthritis (RA). However in last 20 years, it was seen that PsA progresses more aggressive than as considered...

  • Romatoid Artrit ve HastaliÄŸi Modifiye Edici Antiromatizmal ilaçlar. Güzel, Rengin // Turkish Journal of Physical Medicine & Rehabilitation / Turkiye ;mai2008 Supplement, Vol. 54 Issue 1, p25 

    It has now been well established that in Rheumatoid Arthritis early treatment with disease modifying antirheumatic drugs (DMARDs) should be initiated to control the inflammatory activity, structural damage and function. Toxicity of the drugs should be monitored carefully. In cases with...

  • CC chemokine receptor (CCR)-2 prevents arthritis development following infection by Mycobacterium avium. Quinones, Marlon P.; Jimenez, Fabio; Martinez, Hernan; Estrada, Carlos A.; Willmon, Opal; Dudley, Molly; Kuziel, William A.; Melby, Peter C.; Reddick, Robert L.; Ahuja, Sunil K.; Ahuja, Seema S. // Journal of Molecular Medicine;Jun2006, Vol. 84 Issue 6, p503 

    The host factors that influence autoimmune arthritides such as rheumatoid arthritis have not been fully elucidated. We previously found that genetic inactivation of CC chemokine receptor 2 (CCR2) in the arthritis-prone DBA/1j mouse strain significantly increases the susceptibility of this strain...

  • Managing rheumatoid arthritis. Emery, Professor Paul // GP: General Practitioner;4/28/2006, p49 

    The article offers information on the management of rheumatoid arthritis (RA). It is a systemic disease that affects the synovial joints. RA inflammation should be suppressed as early as possible. Previously it was believed that antirheumatic therapy made little, if any, difference to the...

  • Psoriatic Arthritis-New Insights Give New Options for Treatment. Alenius, G. M. // Current Medicinal Chemistry;2007, Vol. 14 Issue 3, p359 

    Psoriatic arthritis (PsA), an inflammatory joint disease associated with psoriasis of the skin, has a heterogeneous pattern expressed by different manifestations, such as mild mono-oligoarthritis, a very severe, erosive and destructive polyarthritis indistinguishable from rheumatoid arthritis,...

  • Expression of multidrug resistance-1 protein correlates with disease activity rather than the refractoriness to methotrexate therapy in rheumatoid arthritis. Agarwal, V.; Mittal, S. K.; Misra, R. // Clinical Rheumatology;Apr2009, Vol. 28 Issue 4, p427 

    Disease-modifying antirheumatic drugs (DMARDs) improve the disability and slow the progression of the joint damage in rheumatoid arthritis (RA). However, a large proportion of patients experience inefficacy by the end of 2 years. This loss of efficacy may be due to expression of multidrug...

  • Adult onset Still’s disease: a study of 14 cases. Singh, S.; Samant, R.; Joshi, V. // Clinical Rheumatology;Jan2008, Vol. 27 Issue 1, p35 

    We studied the clinical profile, laboratory parameters, disease course, and outcomes of patients with adult onset Still’s disease (AOSD). A retrospective analysis of adult patients with Still’s disease diagnosed from 2000 to 2004 was carried out. Their clinical features and...

  • Rheumatoid nodules indicating seronegative rheumatoid arthritis in a patient with gout. Bachmeyer, C.; Charoud, A.; Mougeot-Martin, M. // Clinical Rheumatology;May2003, Vol. 22 Issue 2, p154 

    The association of gout and rheumatoid arthritis is rare. We report the case of a patient with gout who presented with rheumatoid nodules indicating seronegative rheumatoid arthritis.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics